The Director-General, Prof.
Mojisola Adeyeye, said this at a news conference on Monday in Abuja.
National Agency for Food
and Drug Administration and Control (NAFDAC) says it will reduce substandard
and falsified medicines to five per cent prevalence by 2025 in the country.
Adeyeye said that one of
the strategic plans of NAFDAC was to reduce substandard and falsified medicines
to “not more than five per cent prevalence” in Nigeria by the year 2025.
She said that “the last
data we have on the prevalence of substandard and falsified medicines in
Nigeria is 16.7 per cent.”
She, however, added that
the 16.7 per cent prevalence was 14 years ago, noting that it was time the
agency did another survey to determine the present percentage of prevalence of
substandard and falsified medicines in the country.
Adeyeye explained that
NAFDAC had been proactive and vigilant toward curbing substandard and falsified
medicines in the country, stressing that the move became necessary to safeguard
the health of the populace.
She said that the agency
would make it mandatory to identify and test the active pharmaceutical
ingredient in all imported and locally manufactured drugs in the country from
January 2020.
This, according to her, is
to ensure compliance with international standards.
The director-general noted
that besides safeguarding the health of the people, the regulatory control
would also build confidence in Nigerians about the medicines available in the
country.
Adeyeye, who said that
substandard drugs could come through importation, explained that NAFDAC started
enforcing regulations and control of active pharmaceutical ingredients of all
drugs imported or manufactured locally in 2019.
He added that the agency
had been requesting for the drug master file that had the history of processing
and safety of the drugs.
She said that in 2018, the
agency started a country-wide inspection of 165 companies, using the
international standard to ascertain Good Manufacturing Practices (GMP)
compliance.
Adeyeye added that part of
the GMP was the use of appropriate manufacturing equipment and facilities by
manufacturers to ensure adequate control.
She said that measures were
also put in place for the production of quality products.
The Director-General, Prof.
Mojisola Adeyeye, said this at a news conference on Monday in Abuja.
National Agency for Food
and Drug Administration and Control (NAFDAC) says it will reduce substandard
and falsified medicines to five per cent prevalence by 2025 in the country.
Adeyeye said that one of
the strategic plans of NAFDAC was to reduce substandard and falsified medicines
to “not more than five per cent prevalence” in Nigeria by the year 2025.
She said that “the last
data we have on the prevalence of substandard and falsified medicines in
Nigeria is 16.7 per cent.”
She, however, added that
the 16.7 per cent prevalence was 14 years ago, noting that it was time the
agency did another survey to determine the present percentage of prevalence of
substandard and falsified medicines in the country.
Adeyeye explained that
NAFDAC had been proactive and vigilant toward curbing substandard and falsified
medicines in the country, stressing that the move became necessary to safeguard
the health of the populace.
She said that the agency
would make it mandatory to identify and test the active pharmaceutical
ingredient in all imported and locally manufactured drugs in the country from
January 2020.
This, according to her, is
to ensure compliance with international standards.
The director-general noted
that besides safeguarding the health of the people, the regulatory control
would also build confidence in Nigerians about the medicines available in the
country.
Adeyeye, who said that
substandard drugs could come through importation, explained that NAFDAC started
enforcing regulations and control of active pharmaceutical ingredients of all
drugs imported or manufactured locally in 2019.
He added that the agency
had been requesting for the drug master file that had the history of processing
and safety of the drugs.
She said that in 2018, the
agency started a country-wide inspection of 165 companies, using the
international standard to ascertain Good Manufacturing Practices (GMP)
compliance.
Adeyeye added that part of
the GMP was the use of appropriate manufacturing equipment and facilities by
manufacturers to ensure adequate control.
She said that measures were
also put in place for the production of quality products.
No comments:
Post a Comment